|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9400 USD | 0.00% |
|
0.00% | +2.62% |
| Apr. 01 | Zymeworks Inc. Announces Executive Changes, Effective from April 1, 2026 | CI |
| Apr. 01 | Zymeworks Inc. Announces Chief Financial Officer Changes, Effective April 1, 2026 | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.4B | 96.55% | 96.55% | 46.46% | 42.02% | - | |
| 1.52B | 0.72% | 32.72% | 10.49% | 4.68% | - | |
| Average | 1.46B | 48.63% | 64.63% | 28.47% | 23.35% | ||
| Weighted average by Cap. | 1.46B | 52.34% | 67.1% | 29.86% | 24.79% |
- Stock Market
- Equities
- BPCP Stock
- Sector BioPharma Credit PLC
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
